Aripiprazole for treatment of attenuated psychosis syndrome in an adolescent with 22q11.21 deletion syndrome: A case report
This case report represents the therapeutic success achieved with aripiprazole, demonstrating the potential effectiveness of this medication and its potential to improve patient outcomes when it is coupled with cognitive behavioral therapy, highlights the vulnerability of the patient group to antipsychotic-related side effects, and underscores the need for further development of optimized treatment strategies.
Authors
- Samah Hazem Alkhawashki (ORCID: https://orcid.org/0000-0003-2556-9052)
- Norah K. Algarzae (ORCID: https://orcid.org/0000-0002-5286-5394)
- Maha S. Algazlan (ORCID: https://orcid.org/0000-0003-1277-8218)
- Waled M. Albalawi
- Wedad S. Sarawi (ORCID: https://orcid.org/0000-0001-6376-9464)
- Aqeel Alkhiri (ORCID: https://orcid.org/0000-0003-0020-8883)
- Mohammed A. Alhassan (ORCID: https://orcid.org/0000-0002-3009-7187)
Institutions
- Princess Nourah bint Abdulrahman University (SA)
- Majmaah University (SA)
- King Saud Medical City (SA)
- King Saud University (SA)
Publication Details
- Journal
- Medicine
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1097/md.0000000000046652
- Primary Topic
- Congenital heart defects research
- Type
- article
- Field-Weighted Citation Impact
- 0.00